InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.71
(
-0.24%
)
Bitcoin
57,441.82
(
-4.52%
)
Post# of 252480
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: DewDiligence post# 212312

Monday, 07/10/2017 5:11:06 PM

Monday, July 10, 2017 5:11:06 PM

Post# of 252480
ARNA:

Weird data.

I'm a bit confused by the stats they used so can't comment on that and how it dealt with the baseline discrepancies.

But perhaps above all, I'm shocked that the arm with the prostacyclin analogue had better safety results. Especially when tolerability was a major issue at every step with this drug (and this class as a whole).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up